Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
10 juil. 2023 15h59 HE
|
Interpace Biosciences, Inc.
Q2 Revenue of $11 million; a 49.1% increase year-over-year and 12.2% better than Q1; highest quarter in history1st Half Revenue $20.9 million; 36.1% improvement over 1st Half 2022Q2 Test volume up...
Attensi in Pole Position for HR Training
05 mai 2023 03h00 HE
|
Attensi Limited
Global specialist named a Strategic Challenger in 2023 Fosway 9-Grid™ for Digital Learning LONDON, May 05, 2023 (GLOBE NEWSWIRE) -- Gamified learning specialist Attensi has...
Interpace Biosciences Announces First Quarter 2022 Financial and Business Results
16 mai 2022 16h15 HE
|
Interpace Biosciences, Inc.
●Q1 Revenue of $10.4 million up 6% versus Prior Year ●Q1 Net Loss improved $2 million versus Prior Year ●Days Sales Outstanding (DSO) decreased by 27% PARSIPPANY, NJ, May 16, 2022 (GLOBE NEWSWIRE)...
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
11 mai 2021 16h47 HE
|
Interpace Biosciences, Inc.
● Q1 Revenue of $9.8 Million is Company’s Highest as Combined Molecular Diagnostics and Pharma Services Business ● Q2 Revenue Expected to Exceed $11 million ● On Track to Exceed Full Year 2021...
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results
31 mars 2021 17h20 HE
|
Interpace Biosciences, Inc.
2020 Full Year Net Revenue of $32.4 Million Up 34% vs Prior Year; Fourth Quarter Net Revenue of $9.6M Million Up 129% vs Prior Year; Provides Full Year 2021 Range of RevenuesOn Target to Achieve...
Interpace Biosciences Announces Third Quarter 2020 Financial and Business Results and Completion of $5 Million Bridge Loan
20 janv. 2021 08h30 HE
|
Interpace Biosciences, Inc.
Third Quarter Net Revenue of $8.2 Million Up 7% vs Prior Year; Third Quarter Year to Date Net Revenue of $22.8 Million Up 14% vs Prior YearEstimates Fourth Quarter Net Revenue range of $9.0 million -...
Interpace Biosciences Announces First Quarter 2020 Financial and Business Results
25 juin 2020 16h59 HE
|
Interpace Biosciences, Inc.
First Quarter Net Revenue Improved Over 53% to $9.2 Million Launching COVID-19 Serology Testing Continues to Integrate Service Offerings and Streamline Costs Conference Call and Webcast Thursday...
Yesmail Interactive Makes it Easier for Marketers to Optimize Their Email Marketing Through Testing
31 janv. 2013 09h40 HE
|
Yesmail
PORTLAND, Ore., Jan. 31, 2013 (GLOBE NEWSWIRE) -- Yesmail Interactive, an Infogroup company which powers intelligent customer interactions, today announced its new test optimization solution. This new...